Journal Guide

While each volume of Immunological Reviews is devoted to a single topic of immunological research, collectively their aim is to provide a broad and continously updated survey of advances in basic immunology and their clinical applications.

Recognised as one of the leading journals in its fieldOne of the longest established immunology journalsImpact factor 3.674Wide trans-continental representation in authors. editors and reviewersRapid publication with thorough peer-reviewNo page charges for authors#r#r#r#r#r Immunologypublishes papers on fundamental aspects of immunology including:#r#r#r#r#rCellular immunologyInnate immunityMolecular immunologyAntigen presentationLymphocyte migrationImmunogeneticsImaging at the molecular. cellular or whole animal levelProtein crystallographyPlasmon resonanceIn silico modelingKnockout and knock-in studies#r#r#r#r#rOriginal articles describing mechanistic insights to the immune system are particularly welcome.The journal also publishes commissioned review articles on subjects of topical interest to immunologists. The editors are also prepared to consider unsolicited review suggestions in the form of submitted Abstracts.Immunologyis essential reading for workers in all areas of immunological research.#r#r#r#r#r #r#r#r#r#rAims and Scope#r#r#r#r#rRecognised as one of the leading journals in its fieldOne of the longest established immunology journalsImpact factor 3.398Wide trans-continental representation in authors. editors and reviewers#r#r#r#r#r Immunologypublishes papers on fundamental aspects of immunology including:#r#r#r#r#rCellular immunologyInnate immunityMolecular immunologyAntigen presentationLymphocyte migrationImmunogeneticsImaging at the molecular. cellular or whole animal levelProtein crystallographyPlasmon resonanceIn silico modelingKnockout and knock-in studies#r#r#r#r#rOriginal articles describing mechanistic insights to the immune system are particularly welcome.#r#r#r#r#rThe journal also publishes commissioned review articles on subjects of topical interest to immunologists. The editors are also prepared to consider unsolicited review suggestions in the form of submitted Abstracts.#r#r#r#r#rImmunologyis essential reading for workers in all areas of immunological research.#r#r#r#r#rFree Access in the Developing World#r#r#r#r#rFree online access to this journal is available within institutions in the developing world through theHINARIinitiative with the World Health Organization (WHO). and theAGORAinitiative with the Food and Agriculture Organization of the United Nations (FAO).#r#r#r#r#rOnlineOpen#r#r#r#r#rAuthors of articles in this journal can now choose to make their articles open access and available free for all readers through the payment of an author fee.Read more.#r#r#r#r#rReadership#r#r#r#r#rImmunologyprovides a sound advertising medium for related laboratory and pharmaceutical products. See Aims and Scope for more details. The readership includes research workers. university and college lecturers and clinical researchers (approx 80%); and laboratory technicians (20%).

mmunology & Cell Biology focuses on the general functioning of the immune system in its broadest sense, with a particular emphasis on its cell biology.Areas that are covered include but are not limited to: * Cellular immunology * Innate and adaptive immunity * Immune responses to pathogens * Tumour immunology * Immunopathology * Immunotherapy * Immunogenetics * Immunological studies in humans and model organisms (including mouse, rat, Drosophila etc)This leading journal has an established international reputation, built on more than 85 years of innovative publishing. The Journal publishes peer-reviewed Original Articles, Short Communications and Outstanding Observation Articles that describe new research results. Outstanding Observation Articles describe striking reproducible observations that have extremely important conceptual implications but do not necessarily include insights into the underlying molecular mechanism. This manuscript category allows publication of extraordinary findings soon after their discovery. Methodological papers or technical reports of high quality will also be considered for publication as Original Articles or Short Communications. Immunology & Cell Biology also publishes Reviews and News and Commentary articles, which provide succinct summaries of, respectively, an area or a specific research advance in immunology. Landmark articles are brief commentaries which highlight the historical significance of a particular piece of research relevant to the journal's scope. Editorial articles are brief comments written by the editor(s) of the journal or by guest editor(s) of Special Features (see below) based on the contents of the current issue or topical subjects that fall within the scope of the journal. Immunology & Cell Biology occasionally publishes Meeting Reports that briefly detail the discussions, presentations and events at a relevant recent meeting.

Immunology Letters provides a vehicle for the speedy publication of experimental papers, (mini)Reviews and Letters to the Editor addressing all aspects of molecular and cellular immunology. The essential criteria for publication will be clarity, experimental soundness and novelty. Results contradictory to current accepted thinking or ideas divergent from actual dogmas will be considered for publication provided that they are based on solid experimental findings.Preference will be given to papers of immediate importance to other investigators, either by their experimental data, new ideas or new methodology. Scientific correspondence to the Editor-in-Chief related to the published papers may also be accepted provided that they are short and scientifically relevant to the papers mentioned, in order to provide a continuing forum for discussion.Special issues:Suggestions for special issue topics and guest editors can be sent to Deirdre Dunne, d.dunne@elsevier.comBenefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Immunology and Allergy Clinics of North America updates you on the latest trends in patient management; keeps you up to date on the newest advances; and provides a sound basis for choosing treatment options. Each issue focuses on a single topic in immunology and allergy and is presented under the direction of an experienced guest editor. Topics include allergens, immunotherapy, anaphylaxis, asthma, drug allergy, eosinophilrelated disorders, food allergy, immunodeficiency states (non-HIV), basic science, mast cell disorders, rhinitis and sinusitis, and urticaria and angioedema.Immunology and Allergy Clinics of North America is published four times each year, in February, May, August, and November.

he journal Immunopharmacology and Immunotoxicology is devoted to preclinical and clinical studies about the regulatory effects of various agents on immunocompetent cells as well as the immunotoxicity exerted by xenobiotics and drugs. On these bases, the journal encompasses a broad range of pathologies (e.g., acute and chronic infections, allergy, autoimmunity, cancer, degenerative disorders, inflammation and primary and secondary immunodeficiencies).In this framework, the journal will cover new emerging areas of science of broad interest, such as agricultural biotechnology; atherosclerosis; cytokine and growth factor regulation; dendritic cell therapy; food immunology and safety; forensic immunopathology; innate immunity regulation; microbial immunomodulators; mucosal immunity; drug development; psychoneuroimmunology; stem cell therapy; veterinary immunopathology; and vaccines. While articles related to purified extracts may be considered, research on crude botanical extracts are discouraged.Immunopharmacology and Immunotoxicology will accept original manuscripts, brief communications, invited reviews, and clinical cases, on the condition that the results reported are based on original, clinical, or basic research that has not been published elsewhere in any journal in any language (except in abstract form relating to paper communicated to scientific meetings and symposiums).Read More: http://informahealthcare.com/page/ipi/Description.

Immunotherapy offers the scientific community an interdisciplinary forum, providing them with the most recent advances of various aspects of immunotherapeutics to aid navigation of this complex field. Immunotherapy delivers essential information in concise, at-a-glance article formats. Key advances in the field are reported and analyzed by international experts, providing an authoritative but accessible forum for this vitally important area of research

IJMM is the official publication of Indian Association of Medical Microbiologists (IAMM). The journal is peer-reviewed open access publication and published quarterly in January, April, July and October. The journal is abstracted and indexed in PubMed/MEDLINE (National Library of Medicine, USA), Science Citation Index Expanded (Thomson Reuters, USA), EMBASE (Elsevier Science, Netherlands) and IndMed (ICMR, India).IAMM was established in 1976 with the following objectives:"The Association shall promote scientific knowledge of Medical Microbiology and its related subjects, plan and execute projects for the advancement of this knowledge, improve education in Medical Microbiology and promote any programme of professional and ethical standing of Medical Microbiologists in India".

This journal is the official publication of the Association of Microbiologists of India. It publishes full-length papers, short communication reviews and mini reviews on all aspects of microbiological research. Areas of special interest in the journal include agricultural, food, environmental, industrial, medical, pharmaceutical, veterinary and molecular microbiology.

This is a Subscribe to Open journal. The below estimate Article Processing Charges (APCs) are $0.00 but additional page charges will apply. More information here.

Infection and Immunity® publishes research related to infections caused by pathogenic bacteria, fungi, and parasites; molecular mechanisms of pathogenicity; interactions of virulence factors with host cells; innate and adaptive immunity to infection; development of vaccines against nonviral pathogens; and genomes of pathogenic bacteria. IAI also welcomes studies on the interaction of microbial communities with their host.

Infectious diseases constitute one of the main challenges to medical science in the coming century. The impressive development of molecular megatechnologies and of bioinformatics have greatly increased our knowledge of the evolution, transmission and pathogenicity of infectious diseases. Research has shown that host susceptibility to many infectious diseases has a genetic basis. Furthermore, much is now known on the molecular epidemiology, evolution and virulence of pathogenic agents, as well as their resistance to drugs, vaccines, and antibiotics. Equally, research on the genetics of disease vectors has greatly improved our understanding of their systematics, has increased our capacity to identify target populations for control or intervention, and has provided detailed information on the mechanisms of insecticide resistance.However, the genetics and evolutionary biology of hosts, pathogens and vectors have tended to develop as three separate fields of research. This artificial compartmentalisation is of concern due to our growing appreciation of the strong coevolutionary interactions among hosts, pathogens and vectors.Infection, Genetics and Evolution and its companion congress MEEGID (for Molecular Epidemiology and Evolutionary Genetics of Infectious Diseases) are the main forum acting for the cross-fertilization between evolutionary science and biomedical research on infectious diseases.Infection, Genetics and Evolution is the only journal that welcomes articles dealing with the genetics and evolutionary biology of hosts, pathogens and vectors, and coevolution processes among them in relation to infection and disease manifestation. All infectious models enter the scope of the journal, including pathogens of humans, animals and plants, either parasites, fungi, bacteria, viruses or prions. The journal welcomes articles dealing with genetics, population genetics, genomics, postgenomics, gene expression, evolutionary biology, population dynamics, mathematical modeling and bioinformatics.We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Infectious Agents and Cancer is ready to receive manuscripts on all aspects of the pathogenic mechanisms of chronic infections and progression to oncogenesis.

Infectious Disease Clinics of North America updates you on the latest trends in patient management, keeps you up to date on the newest advances, and provides a sound basis for choosing treatment options. Each issue focuses on a single topic in infectious disease, including clinical microbiology, compromised host infections, gastrointestinal infections, global health, hepatitis, HIV/AIDS, hospital-acquired infections, travel medicine, infection control, bacterial infections, sexually transmitted diseases, rrinary tract infections, and viral infections.Infectious Disease Clinics of North America is published four times each year, March, June, September, and December.

Una publicación idónea para mantenerse al día sobre nuevos agentes patógenos, cepas resistentes... mediante los últimos trabajos de investigación clínicos y microbiológicos. Además es la Publicación Oficial de la SEIMC y posee un alto factor de impacto entre los profesionales.10 NÚMEROS AL AÑOPara más información, consulte http://www.elsevier.es/eimc

Medical professionals seeking an infectious diseases journal with true clinical value need look no further than Infectious Diseases in Clinical Practice. Here, clinicians can get full coverage consolidated into one resource, with pertinent new developments presented in a way that makes them easy to apply to patient care. Backed by the expertise and commitment of distinguished clinician-editors, the journal delivers the vital information needed to optimally prevent and treat infectious diseases.Website: www.infectdis.comIndividual and In-Training subscribers receive fully searchable online access to articles from Volume 1 to the present8212;now available on a powerful new website! This best-in-class website platform uses Web 2.0 functionality to provide an enhanced online experience through such features as: saved searches, personal article collections, easy image downloads to PowerPoint, and more.